Maintenance therapy with a combination of azacitidine, danazol, and thalidomide after intensive chemotherapy in patients with acute myeloid leukemia
CONCLUSION: AZA combined with DNZ and THD maintenance therapy is effective for patients with AML who are ineligible for allogeneic hematopoietic stem cell transplantation. Further studies with large sample sizes and randomized are needed to verify these findings.PMID:37916643 | DOI:10.1080/16078454.2023.2276550
Source: Hematology - Category: Hematology Authors: Fang Zheng Qianqian Li Sisi Yang Zhen Zhou Qingfan Zeng Kaiqi Liu Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Chemotherapy | Hematology | International Medicine & Public Health | Leukemia | Stem Cell Therapy | Stem Cells | Study | Transplants | WHO